Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial
Brown et al., The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(23)00147-9
https://c19early.org/brown4.html